摘要
目的:为临床药师参与甲状腺癌术后随访工作提供参考。方法:通过电话、微信的调查方式,随访分化型甲状腺癌术后患者出现的相关症状、服用优甲乐有关的合并用药及服药剂量调整、促甲状腺激素(TSH)的数值变化以及来自食物干扰的情况。结果:促甲状腺激素未达标的231例分化型甲状腺癌患者,术后出现症状的有112例;术后1个月复查,TSH达标者只有41例。而临床药师参与术后随访后,TSH达标总有效人数为201例。结论:临床药师参与分化型甲状腺癌患者的术后随访,可提高患者用药依从性、药物相关知识认知度,使患者饮食和生活习惯更健康,可减轻患者痛苦。
Objective:To provide reference for clinical pharmacists to follow-up patients with differentiated thyroid cancer.Methods:The related symptoms occurred in the postoperative patients with differentiated thyroid cancer,the combined medications and dosage adjustments related to the use of eucalyptus,the changes in the value of thyroid-stimulating hormone(TSH)and the food interference were followed-up by telephone and WeChat survey.Results:One hundred and eleven patients developed the symptoms after surgery among the 231 patients with differentiated thyroid cancer whose thyroid stimulating hormone did not meet the standard.Re-examination was carried out one month after the operation and only 41 cases of TSH reached the standard.However,the total effective number of TSH treatment reached 201 cases after the clinical pharmacist participated in the postoperative follow-up.Conclusion:The medication compliance of patients and the awareness of drug-related knowledge can be improved when clinical pharmacists participate in the postoperative follow-up of differentiated thyroid cancer,which can make the diet and living habits of the patients healthier and relieve their pain.
作者
宋桂芳
董祺
李琳
王文礼
胡静
SONG Guifang;DONG Qi;LI Lin;WANG Wenli;HU Jing(Department of Pharmacy,Shanghai Ruijin Recovery Hospital,Shanghai 200023,China;Department of Acupuncture,Shanghai Ruijin Recovery Hospital,Shanghai 200023,China)
出处
《上海医药》
CAS
2021年第13期67-68,80,共3页
Shanghai Medical & Pharmaceutical Journal
关键词
分化型甲状腺癌
药学服务
术后随访
differentiated thyroid cancer
pharmaceutical care
postoperative follow-up
